Safety and Tolerability Under Research Conditions Commonly monitored signals include GIrelated events (e.g., nausea), changes in heart rate, and laboratory chemistry panels
This gradual progression allows your digestive system, appetite signals, and metabolic response to adapt smoothly, reducing nausea and other adjustment-related side effects
[1] [2] [3] [20] Clinical trials assessing these effects in humans receiving NAD+ injection have not yet been published
The development of reliable non-invasive biomarkers is essential for reducing the dependency on liver biopsies and improving the accuracy of clinical trials
[DOI] [PubMed] [Google Scholar] 228.Eatock MM, Schatzlein A, Kaye SB
A new study from the University of Copenhagen and Hvidovre Hospital in Denmark finds that this is not necessarily the case